MichaelGeorgeMutoMD
Obstetrics & Gynecology • Boston, MAGynecologic Oncology
Associate Professor of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital
Dr. Muto is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
Bwh Division Of Gynecologic Oncology
Boston, MA 02115Phone+1 617-732-8840
Summary
- Dr. Michael Muto is an obstetrician/gynecologist in Boston, MA and is affiliated with multiple hospitals in the area, including South Shore Hospital, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston Children's Hospital, North Shore Medical Center, and Lowell General Hospital. He received his medical degree from UMass Chan Medical School and has been in practice 34 years. He specializes in gynecologic oncology and is experienced in general obstetrics and gynecology, gynecologic oncology, and minimally invasive gynecologic surgery.
Education & Training
Brigham and Women’s HospitalFellowship, Gynecologic Oncology, 1988 - 1990- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Obstetrics and Gynecology, 1983 - 1987
University of Massachusetts Medical SchoolClass of 1983
Certifications & Licensure
MA State Medical License 1987 - 2025- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2008-2014
- Boston Magazine Castle Connolly, 2008-2013
- America's Top Doctors for Cancer Castle Connolly, 2007-2013
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsEndometrial Cancer Risk Among Germline/Pathogenic Variant Carriers: Review of Our Current Understanding and Next Steps.Kimia Sorouri, Filipa Lynce, Colleen M Feltmate, Michelle R Davis, Michael G Muto
JCO Precision Oncology. 2023-09-01 - Durable remission in a patient with-amplified recurrent mucinous ovarian carcinoma treated with Trastuzumab-Carboplatin-Paclitaxel.Alexander J Neil, Michael G Muto, David L Kolin, Panagiotis A Konstantinopoulos
Gynecologic Oncology Reports. 2023-08-01 - 3 citationsPredictive validity of American College of Surgeons: National Surgical Quality Improvement Project risk calculator in patients with ovarian cancer undergoing interval ...Beryl L. Manning-Geist, Ann M. Cathcart, Mackenzie W. Sullivan, Andrea J. Pelletier, Stephanie Cham
International Journal of Gynecological Cancer. 2021-09-13
Journal Articles
- Comparison of Benign Peritoneal Fluid- and Ovarian Cancer Ascites-Derived Extracellular Vesicle RNA BiomarkersRoss S Berkowitz, Michael G Muto, BioMed Central
Other
- Approach to the patient with an adnexal massMuto MG
http://www.uptodate.com/contents/approach-to-the-patient-with-an-adnexal-mass
UpToDate, Wolters Kluwer Health - 2013-01-30 - Management of an adnexal massMuto MG
http://www.uptodate.com/contents/management-of-an-adnexal-mass
UpToDate, Wolters Kluwer Health - 2013-02-26 - Risk-reducing bilateral salpingo-oophorectomy in women at high risk of epithelial ovarian and fallopian tubal cancerMuto MG
http://www.uptodate.com/contents/risk-reducing-bilateral-salpingo-oophorectomy-in-women-at-high-risk
UpToDate, Wolters Kluwer Health - 2013-01-10
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
